Objective: To investigate the factors associated with discrepancies between patient and caregiver reports of the quality of life of patients (QoLp) with Alzheimer disease. Methods: Cross-sectional analytic study of 141 patients and their caregivers. The instruments used were the Quality of Life in AD, the Global Deterioration Scale (GDS), the Geriatric Depression Scale, and the Anosognosia Questionnaire-Dementia. Differences were analyzed according to GDS stage. A linear regression analysis was conducted using the difference between the absolute QoLp scores of patients and caregivers. A cluster analysis involving patient variables was then performed. Results: The discrepancy between patient and caregiver QoLp ratings increased in line with GDS stages (c 2 (2) ¼ 8.7, p ¼ 0.013). In the regression model (F [7,133] ¼ 16.6, p <0.001; R 2 ¼ 0.477), discrepancies in QoLp reports were associated with greater anosognosia, less depression, and a better cognitive status in patients and with female gender among caregivers. The cluster analysis showed that patients with the lowest ratings of QoLp had a better cognitive status, more depression, and less anosognosia. Conversely, the highest ratings were given by patients with a poorer cognitive status, less depression, and greater anosognosia. Conclusions: The factors associated with greater discrepancies between patient and caregiver ratings of QoLp were severity of dementia, anosognosia, depression, and cognitive status in patients and female gender in caregivers. In patients with advanced dementia, greater anosognosia leads to more positive ratings in QoLp and complementary observations are required. (Am J Geriatr Psychiatry 2013; -:-e-)
T he assessment of quality of life is now widely included in clinical guidelines for the treatment of patients with dementia. Indeed, the International Working Group for Harmonization of Dementia Drug Guidelines and the Alzheimer's Society 1 recommend that not only the patient's but also the relatives' and professionals' perceptions of the patient's quality of life be considered when evaluating the effectiveness and appropriateness of therapeutic interventions.
In recent years, an increasing number of studies have examined the factors related to the perceived quality of life of patients (QoLp) with Alzheimer disease. (AD) This research has shown that in patients higher depression scores, 2e4 the presence of behavioral disorders 5e7 and greater functional deficits 8, 9 all have negative effects on QoLp. Among caregivers, poorer ratings of QoLp have been shown to be associated with functional deficits 10, 11 and behavioral disorders 3, 9 in the patient and with burden 3 and depression 12, 13 in the caregiver. Some authors have also reported that perceptions of QoLp are affected by sociodemographic and contextual factors such as the caregiver's gender, 14 his or her relationship to the patient, 15e17 the patient's place of residence, 2, 3 or environmental conditions. 18 Although the assessment of QoLp may be a valid and reliable indicator at any stage of the disease, certain aspects require careful consideration. One of the most important aspects concerns the large discrepancy between patient and caregiver reports of quality of life, 3, 19 which is particularly notable as the severity of dementia increases. 12e20 Other factors to consider in this regard are the influence of depression 21 and reduced awareness of deficits (anosognosia) in the patient. In light of the above, the goals of the present study were as follows: 1) to determine the influence of severity of dementia, depression, and anosognosia as regards the discrepancies between patient and caregiver reports of QoLp and 2) to identify specific groups of patients associated with these discrepancies.
METHODS Design and Study Population
The design was an observational, cross-sectional and analytic study. A consecutive sample was recruited from among outpatients seen at the Dementia Unit of the Neurology Service of the Bellvitge University Hospital (Hospitalet de Llobregat, Spain). All were diagnosed as either AD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria 27 
Instruments
Clinical and sociodemographic data. Sociodemographic data for patients and caregivers were gathered using an ad hoc structured questionnaire.
Measure of quality of life. The Quality of LifeAlzheimer Disease (QoL-AD) scale 30 is designed to assess the QoLp from both the patient's and the caregiver's perspective. It is administered to both patients and caregivers and comprises 13 items that refer to different aspects of the patient's well-being. Scores for each item range from 1 (poor) to 4 (excellent), yielding a total score between 13 and 52; the higher the score, the better the quality of life. The scale's authors consider it to be valid for patients with MMSE scores >10.
Stage of dementia. The criteria applied here were those of the Global Deterioration Scale (GDS). This is a clinical assessment scale designed to determine the stage of a patient's dementia. 31 Depression in the patient and the caregiver. The Geriatric Depression Scale, in its 15-item format, 32 was directly and independently administered to both patients and caregivers. The cut-off score for probable depression is 6.
Anosognosia. The Anosognosia QuestionnaireDementia 33 was administered to patients and caregivers. It comprises 30 items that refer to cognitive/ functional deficits and personality changes, with each item rated according to the frequency of occurrence, from 0 (never) to 3 (always). The total score therefore ranges from 0 to 90, with higher scores indicative of greater anosognosia. The final score is derived by calculating the difference between caregiver and patient scores. The scale's authors consider anosognosia to be present when this difference is !32.
Cognitive assessment of the patient. This was based on MMSE, 29 a brief cognitive assessment whose score ranges from 0 to 30 (the lower the score, the greater the cognitive deterioration).
Functional assessment of the patient. This was based on the Disability Assessment for Dementia, 34 a measure of basic and instrumental ADLs. The Disability Assessment for Dementia comprises 40 items, and its total score ranges from 40 to 80 (the higher the score, the greater the functional capacity).
Behavioral and psychological symptoms of dementia. This aspect was assessed by means of the Neuropsychiatric Inventory, 35 composed of 12 subscales that assess the frequency and severity of 12 neuropsychiatric symptoms. In the present study this assessment was based on information provided by caregivers. Scores range from 0 to 144, and the higher the score, the greater the frequency and severity of behavioral disorders.
Physical and mental health of caregivers. This was assessed using the abbreviated version of the SF-36 Health Survey, 36 a 12-item instrument whose total score ranges from 12 to 28. It yields two global dimensions, physical and mental, on each of which the possible score ranges from 0 to 100 (the higher the score, the better the respondent's health). Caregiver burden. This was assessed using the Caregiver Burden Interview, 37 composed of 22 items that are scored on a Likert scale ranging from 1 (never) to 5 (almost always). The total score therefore ranges between 22 and 110, and the higher the score, the greater the burden.
Procedure
Neurologists from the Dementia Unit identified eligible patients according to the inclusion criteria and determined their degree of dementia in terms of GDS stage. 31 The sample was recruited between January and October 2011. Of the total number of patients who met the inclusion criteria, only four families declined to participate.
In the initial study interview the aims of the research were explained to patients and caregivers, and informed consent was obtained from all participants. Patients and their caregivers were then interviewed separately by two psychologists trained in the administration of the respective tests and instruments.
Statistical Analysis
A descriptive analysis was carried out of the clinical and sociodemographic characteristics of the sample, using absolute and relative frequencies for qualitative variables and measures of central trend and dispersion for quantitative variables. was used for categorical variables. When there was a significant difference between two measures, Cohen's (d) was calculated to determine the effect size. The degree of agreement between patients and caregivers on the QoL-AD was assessed by calculating the corresponding correlation and the intraclass correlation coefficient (ICC). Discrepancies between patient and caregivers ratings on the QoL-AD were measured by taking into account their absolute scores. To analyze the influence of severity of dementia, we compared QoL-AD scores and associated patient and caregiver factors across the different GDS stages.
The patient and caregiver factors that were related to discrepancies in QoL-AD scores were determined through three linear regression analyses using the Enter method (introducing all the variables in a single step). The dependent variables were the QoL-AD scores of the patient and caregiver and the difference between them (patient-caregiver), whereas the independent variables were the clinical and sociodemographic factors. The coefficient of contribution for each variable was calculated by means of the solution suggested by Guilford and Fruchter: 38 beta coefficient Â the coefficient of correlation with the dependent variable. Two-step cluster analysis was then used to identify groups of patients with homogeneous characteristics, introducing the patient variables that were significant in the linear regression analysis and comparing the resulting groups. For hypothesis contrasts the level of statistical significance was set at 0.05. All data processing and analysis was performed using SPSS version 17.0 for Windows (SPSS Inc.; Chicago).
RESULTS

Description of the sample
The final study sample comprised 141 patients and their respective caregivers. Twenty-four of the initial cases (N ¼ 165) were excluded: in 14 cases only the family caregiver could be interviewed, in 1 case only the patient could be interviewed, and in 9 cases the patient had an MMSE score < 10.
The mean age of patients and caregivers was, respectively, 77.6 years (standard deviation [SD]: 7.2) and 63.2 years (SD: 13.4). Eighty-three patients (58.9%) and 101 caregivers (71.6%) were women. Seventy-five caregivers (53.2%) were spouses and 58 (41.1%) were a child of the patient. A total of 118 caregivers (83.7%) lived with the patient. The sociodemographic data are shown in Table 1 .
Clinical Data
Patients. In terms of the severity of dementia, 57 patients (40.4%) met the criteria for GDS stage 4, 46 (32.6%) the criteria for GDS stage 5, and 38 (27.0%) the criteria for GDS stage 6. The mean depression score was 3.6 (SD: 2.9), whereas the mean anosognosia score was 37.3 (SD: 19.9). The mean score on the Neuropsychiatric Inventory was 29.3 (SD: 21.2), with the most intense symptoms being apathy (mean: 5.7; SD: 4.4), irritability (mean: 3.6; SD: 4.1), anxiety (mean: 2.7; SD: 3.6), and aggressiveness (mean: 2.6; SD: 3.5).
Caregivers. The mean score on the Caregiver Burden Interview was 51.9 (SD: 16.1), whereas that for depression (Geriatric Depression Scale) was 4.6 (SD: 3.6). The remaining clinical characteristics of patients and caregivers are presented in Table 2 .
Global Ratings of the QoLp
There were significant differences between the QoLp scores of patients (mean: 34.8; SD: 4.9) and caregivers (mean: 26.6; SD:
The ICC values were low in relation to measures of both absolute agreement (ICC ¼ 0.18; df ¼ 140; 95% confidence interval: e0.12, 
Severity of Dementia and Quality of Life
There were no significant differences in patient reports of QoLp across different GDS stages, whereas caregivers reported poorer QoLp as severity increased. The discrepancy between patient and caregiver scores increased in line with the severity of dementia (GDS stages).
The clinical factors of patients showed a clear deterioration as severity increased, with a reduction in cognitive and functional ability and an increase in neuropsychiatric symptoms on the Neuropsychiatric Inventory, especially apathy (Kruskal-Wallis, (Table 3) .
Depression, Anosognosia, and Quality of Life According to GDS Stage
Higher depression scores among patients were correlated with poorer perceived QoLp at all GDS stages. Depression in caregivers was also globally correlated with a poorer perception of QoLp by the caregiver but was not significant at any one GDS stage.
Higher anosognosia scores among patients were correlated with better perceived QoLp, which remained high across the GDS stages. Conversely, for caregivers greater anosognosia in the patient was inversely correlated with QoLp, especially at GDS stages 4 and 5.
Anosognosia and depression were inversely correlated among patients, especially in the early stages. For caregivers there was a direct correlation between anosognosia and depression, which only reached significance at GDS stage 6.
The common factor among patients and caregivers was the correlation between greater depression and poorer perceived QoLp. The differential factors were the opposing directions of the correlations between anosognosia and QoLp (direct in patients and inverse in caregivers) and between anosognosia and depression (inverse in patients and direct in caregivers) ( Table 3) .
Multivariate Linear Regression Analysis
The regression model for QoLp ratings by patients showed that greater anosognosia and less depression were the main variables associated with higher scores. The regression model for caregiver ratings of QoLp showed that better ratings were associated with less caregiver burden and with the following patient factors: less anosognosia, less depression, and greater functional ability in ADLs (Table 4 ).
The regression model for the differences in QoLp scores between patients and caregivers revealed that the factors showing the greatest positive discrepancy were anosognosia and the MMSE score; in both cases patients scored higher than caregivers. The factor that showed the greatest negative discrepancy was depression in the patient, with patients scoring lower than caregivers. The only caregiver factor associated with discrepancies was gender, with women scoring lower than men.
Clusters of Patients And Caregivers: Associated Factors
When the patient variables that were significant in the linear regression analysis of differences in QoLp scores were introduced into the two-step clustering procedure, two more homogeneous groups were identified ( Table 5 ). The clusters revealed differences in relation to two patient variables, namely QoLp and Geriatric Depression Scale, which did not show differences in the initial analysis based on GDS stages.
Comparison of the two clusters revealed that patients in the first group had a better cognitive status, fewer neuropsychiatric symptoms, and greater functional ability. In other words, their capacities were better preserved. However, patients in this first cluster also presented more depression, less anosognosia, and gave worse ratings of QoLp, compared with those in the second group. Caregivers of patients in the first cluster presented less depression, better mental health and less burden, and also gave better ratings of QoLp.
DISCUSSION
Severity of Dementia and QoLp
The results of the study show that patients' own ratings of their quality of life (QoLp) remained stable in GDS stages despite increasing severity of dementia and greater cognitive, functional, and behavioral deterioration. By contrast, caregiver ratings of QoLp were more consistent with the clinical data, decreasing as the severity of dementia increased. The QoLp ratings of less deteriorated patients were more in line with those of caregivers, with the discrepancy becoming greater as the patient deteriorated further. The observed stability in patients' ratings of QoLp 39, 40 and the decreasing ratings among caregivers has been widely reported. 13, 20 QoLp in the Analysis of Clusters
The cluster analysis identified two groups of patients with different degrees of deterioration. The only difference between the analysis based on GDS stages and the cluster analysis was that the latter revealed significant differences for the patient variables QoLp and depression. This indicates that an approach based on the severity of dementia according to GDS stage is valid when the goal is to observe discrepancies between patients and caregivers. However, if we wish to assess how patient scores evolve, we should also include the patient variables anosognosia and depression, alongside the variables related to cognitive, functional, and behavioral deterioration. In this regard, the cluster analysis identified two groups of patients with different characteristics and perceptions in relation to QoLp ratings.
Depression, Anosognosia, and Quality of Life
The cluster analysis shows that patients with mild deterioration presented less anosognosia, more depression, and a QoLp rating that was closer to that of caregivers. This pattern of results was reversed among more deteriorated patients.
The data show that depression in the patient is associated with more negative ratings of QoLp. The influence of depression is one of the most consistent findings in published research. Among patients the presence of anosognosia was associated with better ratings of QoLp and with greater severity. As regards the latter, the results are consistent with previous studies that have reported greater anosognosia with greater severity of dementia, older age, and more deficits in ADLs. 41, 42 In the present study, depression and anosognosia were inversely correlated among patients. Previous research has produced contradictory findings regarding the relationship between depression and anosognosia: whereas some authors have reported greater depression among anosognosic patients, 42 others have, in line with the present data, found an inverse correlation between depression and anosognosia in the early stages.
43,44
Discrepancies Between Patient and Caregiver Ratings of QoLp
A number of hypotheses can be put forward to explain the discrepancies between patient and caregiver ratings of the patient's quality of life. These are elucidated further below.
Adaptation mechanism. The observed stability in patient ratings of QoLp could be an adaptation mechanism. Indeed, the disability paradox, whereby self-concept remains stable despite disabilities, is well documented. 45 Doubts arise, however, in relation to AD because the cognitive deterioration may be severe in the advanced stages of the disease. The suggestion that patient and caregiver perceptions constitute two unique and different views, both potentially valid, could be included within this perspective.
22,45
Amnesic anosognosia. According to this hypothesis, the self-evaluation of patients would be based erroneously on information stored in their memory. As their recent memory deteriorates further, they would find it increasingly difficult to offer a reliable and up-to-date description of their capacities and health status. 46 If the concept of "the patient's quality of life" is to be useful in verifying the appropriateness of therapeutic interventions, then any evaluation should, as Mack and Whitehouse 1 pointed out, take into account not only the inherent features of the disease (cognitive and functional deterioration) but also associated factors (anosognosia, depression) and contextual aspects (family and social environment).
Conclusions
1. Patient ratings of QoLp remained stable across the stages of dementia, despite the fact that the clinical data showed a progressive deterioration.
2. Anosognosia was associated with a more positive self-appraisal among patients, and its presence increased as AD evolves. In the early stages of the disease, it was inversely correlated with depression. 3. Caregiver ratings of QoLp were lower than those of patients, although the difference between the two was less in the early stages of dementia. 4. Caregiver ratings of QoLp decreased as anosognosia worsened, as the dementia became more severe, and as functional deficits increased. 5. The factors associated with a greater discrepancy between patient and caregiver ratings of QoLp were the severity of dementia, anosognosia, depression, and cognitive status in patients and female gender among caregivers.
Clinical implications. Patients' own ratings of their quality of life should be complemented with measures of anosognosia and depression. Depression in the patient alongside a greater awareness of deficits (less anosognosia) may lead to a more negative appraisal of QoL, especially in the early stages of the disease. Treatment of such depression in the early stages could lead to an improved perception of quality of life. In the later stages, the presence of greater anosognosia may produce an overly positive view of QoLp, and the patient's report should therefore be complemented with other nonverbal observations, as well as with information provided by the caregiver. Caregiver burden should be assessed at all stages of the disease because it may bias caregiver ratings of quality of life and anosognosia. 47 Attention should also be paid to caregivers' needs for practical guidance and emotional support, as such input could lead to a greater understanding and acceptance of their relative's disease. The study has a number of limitations. First, the educational level of caregivers was low, and this may have influenced their (low) ratings of QoLp. Second, data about a possible history of depression in patients may have helped provide a better understanding of the depression factor. Finally, information was lacking about the quality of the previous and current relationship between patients and caregivers, this being an aspect that would likely affect the ratings of QoLp.
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